Publication Name	World Journal of Transplantation
Manuscript ID	4367
Country	United States

Received	2013-06-28 11:23
Peer-Review Started	2013-06-28 17:28
To Make the First Decision	2013-07-19 08:38
Return for Revision	2013-07-19 22:14
Revised	2013-08-26 22:43
Second Decision	2013-10-16 09:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-10-16 10:32
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-12-30 17:04
Publish the Manuscript Online	2013-12-31 17:17

ISSN	2220-3230 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Novel immunosuppressive agents in kidney transplantation
Manuscript Source	Invited Manuscript
All Author List	Karen L Hardinger and Daniel C Brennan
Funding Agency and Grant Number
Corresponding Author	Karen L Hardinger, PharmD, BCPS, Clinical Associate Professor of Pharmacy Practice, Department of Pharmacy Practice and Administration, University of Missouri-Kansas City, 2464 Charlotte Street, Rm 2241, Kansas City, MO 64108, United States. hardingerk@umkc.edu
Key Words	Review; Immunosuppression; Investigational agents; Renal/kidney transplant
Core Tip	Core tip: Many new agents are being studied that may improve outcomes after renal transplantation. Potential improvements to the calcineurin inhibitor class include a recently Food and Drug Administration approved, prolonged release tacrolimus formulation and voclosporin, a cyclosporine analog. A novel, fully-human anti-CD40 monoclonal antibody, ASKP1240, is currently enrolling patients in phase 2 trials with calcineurin minimization and avoidance regimens. Novel treatments for antibody mediated rejection include bortezomib and eculizumab.
Publish Date	2013-12-31 17:17
Citation	Hardinger KL, Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant 2013; 3(4): 68-77
URL	http://www.wjgnet.com/2220-3230/full/v3/i4/68.htm
DOI	http://dx.doi.org/10.5500/wjt.v3.i4.68

Full Article (PDF)	WJT-3-68.pdf
Full Article (Word)	WJT-3-68.doc
Manuscript File	4367-Review.doc
Answering Reviewers	4367-Answering reviewers.pdf
Copyright License Agreement	4367-Copyright assignment.pdf
Peer-review Report	4367-Peer review(s).pdf
Scientific Editor Work List	4367-Scientific editor work list.doc